This is a routine filing with no immediate trading implications. Monitor for any future filings that might indicate a more significant corporate action.
VIR drugs
VIR drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 16 $10.33entry
- T+1 · 7mo ago +4.07%α +2.85% · $10.75
- T+5 · 7mo ago +0.19%α −0.79% · $10.35
- T+20 · 6mo ago −9.68%α −15.50% · $9.33
- T+60 · 4mo ago −5.91%α −12.95% · $9.72
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Vir Biotechnology filed a definitive proxy statement (DEFA14A) following the recent departure of its Chief Medical Officer, Mark Eisner. The filing is routine and does not indicate any material changes or shareholder disputes.
Key Financial Metrics
Key Facts
- Filed a DEFA14A proxy statement
- Follows the recent departure of Chief Medical Officer Mark Eisner
- No activist campaign or shareholder dispute mentioned
- Filing is routine and procedural
Financial Impact
No material financial impact
Risk Factors
- Potential for future management changes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001628280-26-025380 |
| Document: 0001628280-26-025380-index-headers.html | 0001628280-26-025380 |
| Document: 0001628280-26-025380-index.html | 0001628280-26-025380 |
| Document: 0001628280-26-025380.txt | 0001628280-26-025380 |
Track record
36 reports on VIR
4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today 424B5 Bearish 5/10 Entry price pending
- Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
- Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
- Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $13.15 Now $9.58 −27.15% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
- Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
- Nov 2, 202614d ago 144 Neutral 1/10 Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers